Cellectar Biosciences (CLRB) Q4 2023 Earnings

27MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.82
-0.68
-0.54
-0.4

Details

Expected EPS
-0.59
Actual EPS
-0.4
Surprise EPS
0.19
Surprise Percent
+32.2%

Description

Cellectar Biosciences (CLRB) has reported earnings of -0.4 per share for Q4 2023.

0 Comments

Share your thoughts